SpectronRx and RLS team up to give the radiopharmaceutical pipeline and supply chain a much-needed boost

Press releases may be edited for formatting or style | June 09, 2023 Molecular Imaging

About RLS
RLS (Radioisotope Life Sciences) Inc., the third-largest nuclear medicine pharmacy network in the United States, owns and operates 31 radiopharmacies across 18 states, offering an extensive portfolio of molecular imaging products. We endeavor to supply the highest quality radiopharmaceuticals in the industry by dispensing 100 percent of injectable unit dose products in clean rooms built to ISO 1644-1 specifications. In support of our commitment to quality, we provide tailored solutions and exceptional service to our more than 1500 customers.

Back to HCB News

You don’t have to invest heavily in CT technology to achieve your Coronary CTA goals

Fast-moving cardiac structures have a big impact on imaging. Fujifilm’s SCENARIA View premium performance CT brings solutions to address motion in Coronary CTA while delivering unique dose saving and workflow increasing benefits.



You Must Be Logged In To Post A Comment Sign In If you've already created an account, use your email address and password to sign in using the form below. Login Problems: Click here if you are having login issues. Email address: Password: Forgot your password? Login Problems? View our Legal Notice and Privacy Notice Register Registration is Free and Easy. Enjoy the benefits of The World's Leading New & Used Medical Equipment Marketplace. Register Now!

Molecular Imaging Homepage

Cellectar Biosciences and U.S.-based Nusano enter into multi-isotope supply agreement

Alpha-emitting radioisotope expected to play an essential role in next-generation targeted cancer therapies

RefleXion commercializes SCINTIX Therapy: The first and only biology-guided radiotherapy platform

Positrigo closes financing round and appoints new board members

IBA and PET Pharm Bio sign contract to install a Cyclone IKON in Taiwan

GE HealthCare announces FDA clearance for Aurora, dual-head SPECT/CT, and Clarify DL, AI-powered image reconstruction tech

Lantheus completes acquisition of Evergreen Theragnostics

Navigo Proteins announces strategic R&D collaboration with SCK CEN to develop targeted radiotheranostics

PLANET Onco Dose receives EU MDR CE Mark certification

Patients in the US undergo first doses of GE HealthCare's new PET radiotracer, Flyrcado (flurpiridaz F 18) injection

Over 1150 Total Lots Up For Auction at Three Locations - WI 07/09, NJ Cleansweep 07/10, CA 07/11